Executive Summary
Life sciences companies operating at the frontier of cellular medicine face an IT challenge unlike almost any other sector: they must simultaneously protect exceptionally valuable intellectual property, maintain the data integrity and auditability demanded by global regulatory frameworks, support highly skilled technical teams with complex software and data requirements, and do all of this within an infrastructure that can scale alongside a business moving rapidly from research to commercialisation.
This paper outlines the specific challenges of the life sciences operating environment and the standards of IT management those challenges require.
The Life Sciences IT Challenge
For a company developing proprietary cell engineering technology for global pharmaceutical and biotech partners, the stakes of IT failure go far beyond operational inconvenience.
Intellectual Property is the Asset
At a fundamental level, what a cell engineering business has built is knowledge — embodied in research data, process parameters, regulatory filings, partnership agreements and the communications that document the development of its technology platform. The loss, compromise or unauthorised disclosure of any of this information would have consequences that no IT recovery procedure could fully address.
Protecting intellectual property in a digital environment requires more than a firewall. It requires a carefully designed identity and access model, rigorous data classification, auditable file access, and a cloud environment configured to prevent both external attack and inadvertent internal disclosure.
Regulatory Data Integrity
Life sciences businesses operating in this space work in an environment governed by FDA requirements, including 21 CFR Part 11, which mandates specific standards for electronic records and signatures used in regulated manufacturing processes. While the primary compliance responsibility rests with the quality and regulatory teams, the IT infrastructure must not be an obstacle — and in the best case, it actively supports the audit trail, access control and data integrity requirements these frameworks demand.
This means configuring Microsoft 365 to produce reliable audit logs, maintaining appropriate retention policies for regulated data, and ensuring that the identity layer — who can access what, under what conditions — is designed with the same rigour applied to the laboratory environment.
International Collaboration, Controlled Access
Cell therapy development is inherently collaborative. Life sciences companies at this stage work with scientific advisors, academic partners, commercial partners and investors across multiple jurisdictions. The IT environment must support seamless, professional collaboration with external parties while maintaining precise control over what each party can see and access.
Microsoft 365's guest access, External Collaboration settings, and Teams federation capabilities provide the mechanics for this — but only when they are configured deliberately rather than left at default. Misconfigurations in external sharing are among the most common and consequential security gaps in cloud tenants.
The Scaling Infrastructure Problem
Early-stage life sciences companies typically grow through phases: research and development, technology validation, partnership engagement, and eventually the move from research-use-only products toward GMP manufacturing readiness. Each phase places different demands on IT infrastructure, and an environment designed for a small research team can quickly become a liability as commercial operations scale.
Synchronicity's role is to design the infrastructure in a way that serves the current phase while remaining architected for what comes next — avoiding the technical debt that accumulates when IT is treated as a low-priority operational concern.
What Synchronicity Delivers
Microsoft 365 Tenant Governance
We manage the Microsoft 365 environment as a precisely configured, continuously maintained platform. This includes:
- Identity and access management via Microsoft Entra ID, with Conditional Access policies enforcing multi-factor authentication and restricting access by device compliance and location where appropriate
- Exchange Online configuration including anti-phishing, anti-spoofing, DKIM and DMARC — ensuring email is protected inbound and trusted outbound by partner organisations and regulatory recipients
- SharePoint and OneDrive permissions architecture aligned to data classification and the need-to-know principle
- Teams governance including external access configuration, meeting security and channel management
- Microsoft Defender deployment across endpoints and the Microsoft 365 estate
Endpoint Security and Device Management
Every device used to access company data — laptops, mobile devices — is enrolled and managed through Microsoft Intune. Device compliance policies enforce disk encryption, screen lock, patch currency, and application control. This provides both a security baseline and an auditable record of device posture across the organisation.
Backup and Data Continuity
Microsoft 365's native retention capabilities are not a substitute for independent backup. Synchronicity maintains a third-party backup solution covering Exchange Online, SharePoint, OneDrive and Teams — with defined recovery point objectives and tested restoration capability. For an organisation whose data is its primary asset, backup failure is not an acceptable operational risk.
Security Posture and Incident Response
We maintain visibility over the environment through Microsoft's security tooling, respond to security alerts, and advise on emerging threats relevant to the life sciences sector. When the threat landscape changes — new phishing campaigns targeting biotech companies, new vulnerabilities in commonly used tooling — we act proactively rather than waiting for an incident to prompt a review.
Reliable, Responsive Support
Scientific and commercial teams are not IT specialists, nor should they be. Synchronicity provides a responsive support function that resolves issues quickly and communicates clearly about what has happened and what has been done. Technical problems should not become distractions from the work that creates value.
The Compliance Context
In a regulated industry, the quality of your IT environment is not a peripheral concern. It is part of the evidence base that partners, investors and regulators assess when evaluating your organisation.
The primary regulatory work — DMF filing with the FDA, GMP manufacturing readiness, 21 CFR Part 11 electronic record management — is led by quality and regulatory specialists. Synchronicity's role is to ensure that the IT infrastructure supporting these activities is clean, auditable, and does not introduce ambiguity or vulnerability into the compliance picture.
This means maintaining clear audit logs of administrative actions in the Microsoft 365 environment, ensuring data retention policies are aligned with regulatory requirements, and providing documentation of the IT environment that can be reviewed as part of due diligence or regulatory inspection.
Why the Partnership Works
The relationship between Synchronicity and a life sciences client is not a vendor relationship. It is a partnership between specialists — one focused on advanced cell engineering technology, the other on the IT infrastructure that supports it. We invest time in understanding what the business does, why it matters, and what the IT environment needs to enable.
As a life sciences company moves from research toward commercial manufacturing and global partnership engagement, the IT infrastructure must evolve in step. Synchronicity is positioned to guide and execute that evolution, ensuring technology remains an asset rather than a constraint.